Hi All,
I have entered in the stock (Bliss GVS Pharma) at INR 80-95 range. The ratios and outlook seem to be stable. However, the company's revenue sources recently have skewed a lot from India based revenue to international revenue.
Just wanted to check if anyone else too is following the company and what's the opinion of future outlook.
Regards,
Abhishek